Header Logo

Connection

Ajaypal Singh to Kidney Failure, Chronic

Back to Details
This is a "connection" page, showing publications Ajaypal Singh has written about Kidney Failure, Chronic.
Ajaypal Singh
Connection Strength
6.393
Kidney Failure, Chronic
  1. Sudden cardiac arrest in ESRD patients. Clin Nephrol. 2014 Feb; 81(2):121-31.
    View in: PubMed
    Score: 0.416
  2. Con: Randomized controlled trials (RCT) have failed in the study of dialysis methods. Nephrol Dial Transplant. 2013 Apr; 28(4):826-32; discussion 832.
    View in: PubMed
    Score: 0.392
  3. Pro: The value of randomized controlled studies in dialysis methods. Nephrol Dial Transplant. 2013 Apr; 28(4):834-5; discussion 835-6.
    View in: PubMed
    Score: 0.392
  4. Diabetes, anemia and CKD: Why TREAT? Curr Diab Rep. 2010 Aug; 10(4):291-6.
    View in: PubMed
    Score: 0.326
  5. Therapy with erythropoiesis-stimulating agents and renal and nonrenal outcomes. Heart Fail Clin. 2010 Jul; 6(3):323-32.
    View in: PubMed
    Score: 0.324
  6. Anemia in chronic kidney disease: new advances. Heart Fail Clin. 2010 Jul; 6(3):347-57.
    View in: PubMed
    Score: 0.324
  7. Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions. Semin Nephrol. 2009 Mar; 29(2):105-12.
    View in: PubMed
    Score: 0.295
  8. Role of vitamin D in chronic kidney disease. Semin Nephrol. 2009 Mar; 29(2):113-21.
    View in: PubMed
    Score: 0.295
  9. Endothelial activation markers in anemic non-dialysis chronic kidney disease patients. Nephron Clin Pract. 2008; 110(4):c244-50.
    View in: PubMed
    Score: 0.289
  10. Iron deficiency in non-dialysis chronic kidney disease. Kidney Int. 2009 Apr; 75(7):752-4.
    View in: PubMed
    Score: 0.281
  11. Pure red cell aplasia due to follow-on epoetin. Kidney Int. 2008 Dec; 74(12):1617-22.
    View in: PubMed
    Score: 0.281
  12. Acute coronary syndrome in ESRD patients. Kidney Int. 2009 Mar; 75(5):558-62.
    View in: PubMed
    Score: 0.280
  13. The optimal hemoglobin in dialysis patients- a critical review. Semin Dial. 2008 Jan-Feb; 21(1):1-6.
    View in: PubMed
    Score: 0.273
  14. Is it time to reconsider subcutaneous administration of epoetin? Nephrol News Issues. 2007 Oct; 21(11):57, 59, 63-4 passim.
    View in: PubMed
    Score: 0.268
  15. Anaemia of CKD--the CHOIR study revisited. Nephrol Dial Transplant. 2007 Jul; 22(7):1806-10.
    View in: PubMed
    Score: 0.259
  16. The target hemoglobin in patients with chronic kidney disease. Nephrol News Issues. 2006 Dec; 20(13):29-30.
    View in: PubMed
    Score: 0.253
  17. Complications of chronic kidney disease: anemia, mineral metabolism, and cardiovascular disease. Med Clin North Am. 2005 May; 89(3):549-61.
    View in: PubMed
    Score: 0.227
  18. The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease. Nephrol Nurs J. 2005 Mar-Apr; 32(2):199-206; quiz 207-8.
    View in: PubMed
    Score: 0.224
  19. Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2019 11; 28(6):600-606.
    View in: PubMed
    Score: 0.155
  20. A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease. Am J Nephrol. 2017; 46(5):364-370.
    View in: PubMed
    Score: 0.135
  21. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type?2 Diabetic Patients With CKD. Am J Kidney Dis. 2017 Oct; 70(4):522-531.
    View in: PubMed
    Score: 0.131
  22. C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2016 Dec; 68(6):873-881.
    View in: PubMed
    Score: 0.125
  23. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med. 2010 Sep 16; 363(12):1146-55.
    View in: PubMed
    Score: 0.082
  24. The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now? Am J Kidney Dis. 2008 Dec; 52(6 Suppl):S5-13.
    View in: PubMed
    Score: 0.073
  25. Managing anemia in dialysis patients: hemoglobin cycling and overshoot. Kidney Int. 2008 Sep; 74(5):679-83.
    View in: PubMed
    Score: 0.069
  26. Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin. J Am Soc Nephrol. 2008 Feb; 19(2):372-9.
    View in: PubMed
    Score: 0.068
  27. Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database. Transplantation. 2006 Sep 15; 82(5):612-8.
    View in: PubMed
    Score: 0.062
  28. Uncertainty in the treatment of anemia in chronic kidney disease. Rev Cardiovasc Med. 2005; 6 Suppl 3:S35-41.
    View in: PubMed
    Score: 0.055
  29. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009 Nov 19; 361(21):2019-32.
    View in: PubMed
    Score: 0.019
  30. Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization. Am J Kidney Dis. 2009 Sep; 54(3):498-510.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.